PMMI research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome ...

Explore key identity management challenges in pharma and biotech SaaS platforms and learn practical solutions for security, compliance, and scalability.

Staying ahead of pharma supply challenges rests on anticipatory pillars and does not require reinventing the wheel, says ...

PMMI research identifies top manufacturing hurdles including regulatory compliance, automation needs, and sustainability priorities ...

Pharma's investment in the digital health space is getting more and more real and substantive as companies move beyond the pilot stage and start to launch real digital health interventions, from Teva ...

Pharmaceutical Cliff Diving is a consultancy-style report which identifies, assesses, and provides insights on the key challenges that industry is experiencing now and in the near future. Through CBR ...

Merck's affordable Ebola vaccine initiatives, Abbott's profit challenges, U.S. vaccination policy changes under Health ...

With large pharma companies now confronting a two-pronged assault on U.S. | On Wednesday, the U.S. Chamber of Commerce filed an amicus brief calling on the Supreme Court to review a lower court ...

Tuesday, Ascendis Pharma A/S (NASDAQ:ASND) reported second-quarter sales of $38.76 million (35.9 million euros), missing the consensus of $92.7 million, down from 47.4 million euros reported a year ...

A pharmaceutical company is currently appealing a record USD1.6 billion judgment in the US, arguing that a key part of the US False Claims Act (FCA) is unconstitutional. This case, now before the ...

Cantor Fitzgerald writes that the Skytrofa update probably overshadowed another key update from the call. Achieving breakeven this year is unlikely unless the company significantly reduces costs, ...